粪便微生物群谱作为原发性硬化性胆管炎的诊断生物标志物 - Suppr

Suppr

超能文献

Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis.

作者信息

Rühlemann Malte Christoph, Heinsen Femke-Anouska, Zenouzi Roman, Lieb Wolfgang, Franke Andre, Schramm Christoph

机构信息

Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, Kiel, Germany.

First Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

出版信息

Gut. 2017 Apr;66(4):753-754. doi: 10.1136/gutjnl-2016-312180. Epub 2016 May 23.

DOI:10.1136/gutjnl-2016-312180

PMID:27216937

Abstract

摘要

相似文献

Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis.

Gut. 2017 Apr;66(4):753-754. doi: 10.1136/gutjnl-2016-312180. Epub 2016 May 23.

Response to 'Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis' by Rühlemann .

Gut. 2017 Apr;66(4):755-756. doi: 10.1136/gutjnl-2016-312347. Epub 2016 Jun 23.

Characterisation of the faecal microbiota in Japanese patients with paediatric-onset primary sclerosing cholangitis.

Gut. 2017 Jul;66(7):1344-1346. doi: 10.1136/gutjnl-2016-312533. Epub 2016 Sep 26.

Editorial: gut microbial profile associated with primary sclerosing cholangitis-what is new and how do we progress from here?

Aliment Pharmacol Ther. 2019 Sep;50(5):605-606. doi: 10.1111/apt.15424.

Editorial: gut microbial profile associated with primary sclerosing cholangitis-what is new and how do we progress from here? Authors' reply.

Aliment Pharmacol Ther. 2019 Sep;50(5):606-607. doi: 10.1111/apt.15434.

Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a pilot study.

Dig Liver Dis. 2012 Apr;44(4):303-10. doi: 10.1016/j.dld.2011.10.025. Epub 2011 Dec 9.

Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases.

Autoimmun Rev. 2017 Sep;16(9):885-896. doi: 10.1016/j.autrev.2017.07.002. Epub 2017 Jul 8.

Sclerosing cholangitis.

Curr Opin Gastroenterol. 2006 May;22(3):288-93. doi: 10.1097/01.mog.0000218966.78558.67.

Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis.

World J Gastroenterol. 2017 Jul 7;23(25):4548-4558. doi: 10.3748/wjg.v23.i25.4548.

Proctocolectomy for ulcerative colitis after liver transplantation for primary sclerosing cholangitis.

Transplant Proc. 2009 May;41(4):1390-2. doi: 10.1016/j.transproceed.2009.03.027.

引用本文的文献

Treatment of cholangiocarcinoma in patients with primary sclerosing cholangitis: a comprehensive review.

eGastroenterology. 2024 Mar 29;2(1):e100045. doi: 10.1136/egastro-2023-100045. eCollection 2024 Jan.

Biliary fibrosis is an important but neglected pathological feature in hepatobiliary disorders: from molecular mechanisms to clinical implications.

Med Rev (2021). 2024 Jul 1;4(4):326-365. doi: 10.1515/mr-2024-0029. eCollection 2024 Aug.

Protective function of sclerosing cholangitis on IBD.

Gut. 2024 Jul 11;73(8):1292-1301. doi: 10.1136/gutjnl-2023-330856.

Causal effects of gut microbiome on autoimmune liver disease: a two-sample Mendelian randomization study.

BMC Med Genomics. 2023 Oct 3;16(1):232. doi: 10.1186/s12920-023-01670-0.

Factors associated with severity and persistence of fatigue in patients with primary biliary cholangitis: study protocol of a prospective cohort study with a mixed-methods approach (SOMA.LIV).

BMJ Open. 2022 Dec 7;12(12):e061419. doi: 10.1136/bmjopen-2022-061419.

Role of intestinal flora in primary sclerosing cholangitis and its potential therapeutic value.

World J Gastroenterol. 2022 Nov 28;28(44):6213-6229. doi: 10.3748/wjg.v28.i44.6213.

Potential Role of Inflammation-Promoting Biliary Microbiome in Primary Sclerosing Cholangitis and Cholangiocarcinoma.

Cancers (Basel). 2022 Apr 24;14(9):2120. doi: 10.3390/cancers14092120.

The intestinal and biliary microbiome in autoimmune liver disease-current evidence and concepts.

Semin Immunopathol. 2022 Jul;44(4):485-507. doi: 10.1007/s00281-022-00936-6. Epub 2022 May 10.

Altered Gut Microbiota as an Auxiliary Diagnostic Indicator for Patients With Fracture-Related Infection.

Front Microbiol. 2022 Apr 14;13:723791. doi: 10.3389/fmicb.2022.723791. eCollection 2022.

Circulating microbiome in patients with portal hypertension.

Gut Microbes. 2022 Jan-Dec;14(1):2029674. doi: 10.1080/19490976.2022.2029674.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis.

作者信息

Rühlemann Malte Christoph, Heinsen Femke-Anouska, Zenouzi Roman, Lieb Wolfgang, Franke Andre, Schramm Christoph

机构信息

Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, Kiel, Germany.

First Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

出版信息

Gut. 2017 Apr;66(4):753-754. doi: 10.1136/gutjnl-2016-312180. Epub 2016 May 23.

DOI:10.1136/gutjnl-2016-312180

PMID:27216937

Abstract

摘要

相似文献

Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis.

Gut. 2017 Apr;66(4):753-754. doi: 10.1136/gutjnl-2016-312180. Epub 2016 May 23.

Response to 'Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis' by Rühlemann .

Gut. 2017 Apr;66(4):755-756. doi: 10.1136/gutjnl-2016-312347. Epub 2016 Jun 23.

Characterisation of the faecal microbiota in Japanese patients with paediatric-onset primary sclerosing cholangitis.

Gut. 2017 Jul;66(7):1344-1346. doi: 10.1136/gutjnl-2016-312533. Epub 2016 Sep 26.

Editorial: gut microbial profile associated with primary sclerosing cholangitis-what is new and how do we progress from here?

Aliment Pharmacol Ther. 2019 Sep;50(5):605-606. doi: 10.1111/apt.15424.

Editorial: gut microbial profile associated with primary sclerosing cholangitis-what is new and how do we progress from here? Authors' reply.

Aliment Pharmacol Ther. 2019 Sep;50(5):606-607. doi: 10.1111/apt.15434.

Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a pilot study.

Dig Liver Dis. 2012 Apr;44(4):303-10. doi: 10.1016/j.dld.2011.10.025. Epub 2011 Dec 9.

Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases.

Autoimmun Rev. 2017 Sep;16(9):885-896. doi: 10.1016/j.autrev.2017.07.002. Epub 2017 Jul 8.

Sclerosing cholangitis.

Curr Opin Gastroenterol. 2006 May;22(3):288-93. doi: 10.1097/01.mog.0000218966.78558.67.

Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis.

World J Gastroenterol. 2017 Jul 7;23(25):4548-4558. doi: 10.3748/wjg.v23.i25.4548.

Proctocolectomy for ulcerative colitis after liver transplantation for primary sclerosing cholangitis.

Transplant Proc. 2009 May;41(4):1390-2. doi: 10.1016/j.transproceed.2009.03.027.

引用本文的文献

Treatment of cholangiocarcinoma in patients with primary sclerosing cholangitis: a comprehensive review.

eGastroenterology. 2024 Mar 29;2(1):e100045. doi: 10.1136/egastro-2023-100045. eCollection 2024 Jan.

Biliary fibrosis is an important but neglected pathological feature in hepatobiliary disorders: from molecular mechanisms to clinical implications.

Med Rev (2021). 2024 Jul 1;4(4):326-365. doi: 10.1515/mr-2024-0029. eCollection 2024 Aug.

Protective function of sclerosing cholangitis on IBD.

Gut. 2024 Jul 11;73(8):1292-1301. doi: 10.1136/gutjnl-2023-330856.

Causal effects of gut microbiome on autoimmune liver disease: a two-sample Mendelian randomization study.

BMC Med Genomics. 2023 Oct 3;16(1):232. doi: 10.1186/s12920-023-01670-0.

Factors associated with severity and persistence of fatigue in patients with primary biliary cholangitis: study protocol of a prospective cohort study with a mixed-methods approach (SOMA.LIV).

BMJ Open. 2022 Dec 7;12(12):e061419. doi: 10.1136/bmjopen-2022-061419.

Role of intestinal flora in primary sclerosing cholangitis and its potential therapeutic value.

World J Gastroenterol. 2022 Nov 28;28(44):6213-6229. doi: 10.3748/wjg.v28.i44.6213.

Potential Role of Inflammation-Promoting Biliary Microbiome in Primary Sclerosing Cholangitis and Cholangiocarcinoma.

Cancers (Basel). 2022 Apr 24;14(9):2120. doi: 10.3390/cancers14092120.

The intestinal and biliary microbiome in autoimmune liver disease-current evidence and concepts.

Semin Immunopathol. 2022 Jul;44(4):485-507. doi: 10.1007/s00281-022-00936-6. Epub 2022 May 10.

Altered Gut Microbiota as an Auxiliary Diagnostic Indicator for Patients With Fracture-Related Infection.

Front Microbiol. 2022 Apr 14;13:723791. doi: 10.3389/fmicb.2022.723791. eCollection 2022.

Circulating microbiome in patients with portal hypertension.

Gut Microbes. 2022 Jan-Dec;14(1):2029674. doi: 10.1080/19490976.2022.2029674.